Session Information
Date: Monday, June 5, 2017
Session Title: Parkinson's Disease: Non-Motor Symptoms
Session Time: 1:45pm-3:15pm
Location: Exhibit Hall C
Objective: To examine the frequency and risk factors of excessive daytime sleepiness (EDS) in patients with PD and to determine relationships between EDS and another symptoms of PD.
Background: EDS is a frequent symptom in PD and seems to be multifactorial by nature. The risk factors of EDS and associations with another symptoms are not enough investigated.
Methods: PD patients [N=32 (18M); 64,7±6,3 years old; 4,4±3,15 (0.3-12) years motor disease duration, HY range 1-3, and mean MoCA score 25.5±1.9 (22-29)] underwent clinical evaluation including the Epworth Sleepiness Scale (ESS) and the Parkinson’s disease sleep scale – 2 (PDSS-2), the Hoehn and Yahr scale and the MDS-Unified Parkinson’s disease rating scale (MDS-UPDRS), the Parkinson’s disease questionnaire (PDQ-39), Schwab and England Activities of Daily Living Rating (SE-ADL) and Hospital anxiety and depression scale (HADS). EDS was diagnosed according to the ESS, cutoff score above 10 was applied. All patients with EDS underwent one-night video-polysomnography study and the multiple sleep latency test (MSLT).
Results: 50% of patients had EDS. Baseline characteristics were similar between patients with and without EDS. Patients with EDS had higher PDSS-2 score (p=0,002), more prominent autonomic dysfunction and cognitive impairment (p=0,01), worse quality of life and lower daytime activity (p<0,01). EDS was associated with higher levodopa equivalent dose (LED) (633,8 versus 280,0; p=0,002), longer duration of therapy and part I, II and total MDS-UPDRS higher score (p=0,01). The mean time of sleep was 6,7±1,1 hours, index of sleep quality was 76,2±12,7%. Patients had reduced amount of deep wave sleep and a lot of awakenings. 31% had obstructive sleep apnea (OSA), but mean oxygen saturation was 93,8±1,3. The mean sleep latency (SL) was 7,5±4,3 min. Correlation between the apnea-hypopnea index (AHI) and mean SL was not found.
Conclusions: E
EDS occurs in 50% of patients with PD and associated with higher MDS-UPDRS score, more frequent autonomic dysfunction, cognitive impairment, higher LED, lower quality of life and daytime activity. Patients with EDS have fragmented sleep, but sleep duration is sufficient. 31% of patients had AHI>5, that indicates a wide frequency of OSA in PD and a potential role in genesis of EDS. However, SL values in such patients and absence of oxygen desaturation profile of OSA suggest the “abortive” OSA.
To cite this abstract in AMA style:
O. Babkina, O. Levin, M. Poluektov. Excessive daytime sleepiness in Parkinson’s disease: risk factors and clinical associations [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/excessive-daytime-sleepiness-in-parkinsons-disease-risk-factors-and-clinical-associations/. Accessed November 21, 2024.« Back to 2017 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/excessive-daytime-sleepiness-in-parkinsons-disease-risk-factors-and-clinical-associations/